中国现代医学杂志
中國現代醫學雜誌
중국현대의학잡지
CHINA JOURNAL OF MODERN MEDICINE
2004年
21期
15-17,21
,共4页
姚丽%西山成%安部阳一%王力宁
姚麗%西山成%安部暘一%王力寧
요려%서산성%안부양일%왕력저
醛固酮%高血压%肾损伤%MAPKs
醛固酮%高血壓%腎損傷%MAPKs
철고동%고혈압%신손상%MAPKs
aldosterone%hypertension%renal injury%MAPKs
目的探讨MAPKs激活在慢性醛固酮灌注诱发高血压肾损伤中的作用.方法6周SD大鼠随机分组为对照组,醛固酮/盐组及醛固酮拮抗剂eplerenone治疗组,采用Westem blotting技术检测各组大鼠肾皮质组织MAPKs亚型ERK1/2,JNK及p38MAPK活性.结果醛固酮/盐组大鼠血压显著升高,肾重/体重比值增加,尿蛋白排泄量增加,其肾皮质组织ERK1/2及JNK活性明显升高(P<0.05).eplerenone治疗降低了醛固酮诱发的高血压,蛋白尿以及肾皮质MApKs活性.结论MAPKs激活与慢性醛固酮灌注致高血压肾损伤密切相关,Eplerenone其具有肾脏保护作用.
目的探討MAPKs激活在慢性醛固酮灌註誘髮高血壓腎損傷中的作用.方法6週SD大鼠隨機分組為對照組,醛固酮/鹽組及醛固酮拮抗劑eplerenone治療組,採用Westem blotting技術檢測各組大鼠腎皮質組織MAPKs亞型ERK1/2,JNK及p38MAPK活性.結果醛固酮/鹽組大鼠血壓顯著升高,腎重/體重比值增加,尿蛋白排洩量增加,其腎皮質組織ERK1/2及JNK活性明顯升高(P<0.05).eplerenone治療降低瞭醛固酮誘髮的高血壓,蛋白尿以及腎皮質MApKs活性.結論MAPKs激活與慢性醛固酮灌註緻高血壓腎損傷密切相關,Eplerenone其具有腎髒保護作用.
목적탐토MAPKs격활재만성철고동관주유발고혈압신손상중적작용.방법6주SD대서수궤분조위대조조,철고동/염조급철고동길항제eplerenone치료조,채용Westem blotting기술검측각조대서신피질조직MAPKs아형ERK1/2,JNK급p38MAPK활성.결과철고동/염조대서혈압현저승고,신중/체중비치증가,뇨단백배설량증가,기신피질조직ERK1/2급JNK활성명현승고(P<0.05).eplerenone치료강저료철고동유발적고혈압,단백뇨이급신피질MApKs활성.결론MAPKs격활여만성철고동관주치고혈압신손상밀절상관,Eplerenone기구유신장보호작용.
Objective: To discuss the effect of mitogen-aetivated protein kinase (MAPKs) activation in aldosterone infused to induce the renal injury. Methods: 6 weeks Sprague-Dawley rats were divided into two groups.The control group: 1% NaC1 + vehicle (0.5% ethanol, n =8). The treatment group: 1% NaC1 + aldosterone (0.75% (g/rin, n =8), 1%NaCl + aldosterone + a selective mineralocorticoid receptor antagonist, eplerenone (0.125% in chow,n =8). The activities of MAPKs subfamilies, including ERK 1/2, JNK and p38-MAPK, in renal cortical tissues were measured by Western blot analysis. Results: Aldosterone-infused rats showed higher blood pressure and urinary excretion of protein increased. Renal cortical ERK 1/2 and JNK activities were significantly increased (P <0.05). Concurrent administration of eplerenone prevented the development of hypertension and elevation in urinary excretion of protein. Furthermore, eplerenone treatment normalized the activities of ERK 1/2 and JNK. Conclusions: These data support the concept that in aldosterone-infused hypertensive rats, MAPKs activation contributes to the progression of renal injury. A selective mineralocorticoid receptor antagonist, eplerenone showed renoprotective effects in this model.